Cargando…
TOM70 in Glial Cells as a Potential Target for Treatment of COVID-19
Autores principales: | Montenegro, Yorran Hardman Araújo, Zanatta, Geancarlo, Quincozes-Santos, André, Leipnitz, Guilhian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740195/ https://www.ncbi.nlm.nih.gov/pubmed/35002631 http://dx.doi.org/10.3389/fncel.2021.811376 |
Ejemplares similares
-
Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins
por: Gonçalves, Carlos-Alberto, et al.
Publicado: (2022) -
Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders
por: Seminotti, Bianca, et al.
Publicado: (2021) -
Acute Liver Failure Induces Glial Reactivity, Oxidative Stress and Impairs Brain Energy Metabolism in Rats
por: Guazzelli, Pedro Arend, et al.
Publicado: (2020) -
Application of optogenetic glial cells to neuron–glial communication
por: Hyung, Sujin, et al.
Publicado: (2023) -
Editorial: Glial-targeted therapeutics for CNS disease: getting there from here
por: Tansey, Malú Gámez, et al.
Publicado: (2023)